Results 101 to 110 of about 73,252 (267)

Fluorescent Protein Expressing Rickettsia buchneri and Rickettsia peacockii for Tracking Symbiont-Tick Cell Interactions

Veterinary Sciences, 2016
Rickettsiae of indeterminate pathogenicity are widely associated with ticks. The presence of these endosymbionts can confound a One Health approach to combatting tick-borne diseases.
Timothy J. Kurtti, Nicole Y. Burkhardt, Chan C. Heu, Ulrike G. Munderloh   +3 more
doaj   +1 more source

Health Concerns in Cambodia Compounded by Historical and Rural Setbacks [PDF]

, 2020
Cambodia is a country in the Greater Mekong Subregion of Southeast Asia. The Khmer Rouge genocide in the mid 1970s produced significant setbacks in the nation’s healthcare system.
DeHart, Ciera
core   +1 more source

Konstruksi mutasi daerah resisten rifampin (gen rpoB) dari Mycobacterium leprae pada penderita lepra di Surabaya melalui analisis genom hasil PCR

Journal of Biological Researches, 2012
Rifampin is a key component in the chemoterapeutic regimens used to combat both leprosy and tuberculosis. Owing to exquisite rifampin susceptibility of Mycobacterium leprae, this drug is the backbone of the multidrug therapy currently recommended by WHO
E Bimo Aksono H
doaj   +1 more source

Antimicrobial Treatment of Orthopedic Implant-related Infections with Rifampin Combinations [PDF]

, 2017
The purpose of this prospective clinical study is to evaluate the role of combination chemotherapy with rifampin in the treatment of orthopedic device—related infections in which the implant could not be removed.
Gaechter, Andre, Ochsner, Peter E., Widmer, Andreas F., Zimmerli, Werner   +3 more
core  

Rifampin-resistantNeisseria meningitidis [PDF]

, 2006
Muhamed‐Kheir Taha, Leticia Zarantonelli, Corinne Ruckly, Dario Giorgini, Jean‐Michel Alonso   +4 more
openalex   +1 more source

Peer Review #1 of "Differential effects of cotreatment of the antibiotic rifampin with host-directed therapeutics in reducing intracellular Staphylococcus aureus infection (v0.1)"

, 2020
Melissa D. Evans, Robert Erik Sammelson, Susan A. McDowell, S Tong, J Davis, E Eichenberger, T Holland, V Fowler, N Kavanagh, E Ryan, A Widaa, G Sexton, J Fennell, S O'rourke, K Cahill, C Kearney, F O'brien, S Kerrigan, C Goss, M Muhlebach, D Armstrong, K Grimwood, J Carlin, R Carzino, J Gutierrez, J Hull, A Olinsky, E Phelan, C Robertson, P Phelan, C Branger, C Gardye, N Lambert-Zechovsky, M Schwerdt, C Neumann, B Schwartbeck, S Kampmeier, S Herzog, D Gorlich, A Dubbers, J Grosse-Onnebrink, C Kessler, P Kuster, H Schultingkemper, J Treffon, G Peters, B Kahl, J Hatzenbuehler, T Pulling, B Loffler, L Tuchscherr, S Niemann, G Peters, R Proctor, C Eiff, B Kahl, K Becker, P Mcnamara, M Herrmann, G Peters, L Tuchscherr, E Medina, M Hussain, W Volker, V Heitmann, S Niemann, D Holzinger, J Roth, R Proctor, K Becker, G Peters, B Loffler, T Foster, J Geoghegan, V Ganesh, M Hook, M Horn, S Knecht, F Rushing, J Birdsong, C Siddall, C Johnson, T Abraham, A Brown, C Volk, K Gammon, D Bishop, J Mckillip, S Mcdowell, F Agerer, S Lux, A Michel, M Rohde, K Ohlsen, C Hauck, C Nobes, A Hall, L Arbibe, J Mira, N Teusch   +99 more
openalex   +2 more sources

Liquid Chromatographic Determination of Rifampin In Human Plasma, Bronchoalveolar Lavage Fluid, and Alveolar Cells [PDF]

, 2000
John E. Conte, E T Lin, E. Zurlinden
openalex   +1 more source

Rifampin in Experimental Endocarditis Due to Staphylococcus aureus in Rabbits [PDF]

, 2017
Rifampin possesses unique activity against Staphylococcus aureus. It is the most active antistaphylococcal antibiotic currently available and has been shown to be particularly effective in eradicating S.
Sande, Merle A., Scheid, W. Michael, Zak, Oto   +2 more
core  

Rifalazil Retains Activity Against Rifampin-resistant Mutants of Chlamydia pneumoniae [PDF]

, 2008
David M. Rothstein, Robert J. Suchland, Minsheng Xia, Christopher K. Murphy, Walter E. Stamm   +4 more
openalex   +1 more source

Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia [PDF]

, 2017
We present the case of a patient with ventilator-associated pneumonia (VAP) caused by a pan-resistant Acinetobacter baumannii successfully treated with the combination colistin plus vancomycin plus rifampin, whose in vitro activity was investigated by ...
Cipolla, Alessia, Falcone, Marco, Mastroianni, Claudio Maria, Oliva, Alessandra, Venditti, Mario, Vullo, Vincenzo   +5 more
core   +1 more source